DHG Pharmaceutical JSC (DHG) — Capital Reinvestment Ratio
DHG Pharmaceutical JSC (DHG) has a Capital Reinvestment Ratio of 0.20x as of June 2026, meaning it reinvests 0% of its operating cash flow (₫214.23 Billion) in capital expenditures (₫42.28 Billion). Check tangible equity quality of DHG Pharmaceutical JSC to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DHG Pharmaceutical JSC Capital Reinvestment Ratio (2019–2025)
This chart tracks DHG Pharmaceutical JSC's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see DHG Pharmaceutical JSC operating cash flow efficiency.
Annual Capital Reinvestment Ratio for DHG Pharmaceutical JSC (2019–2025)
Year-by-year Capital Reinvestment Ratio for DHG Pharmaceutical JSC from 2019 to 2025. See DHG Pharmaceutical JSC free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₫1.21 Trillion | ₫31.14 Billion | ▼ -61.9% |
| 2024 | 0.07x | ₫1.32 Trillion | ₫88.70 Billion | ▼ -95.6% |
| 2023 | 1.55x | ₫279.88 Billion | ₫432.73 Billion | ▲ +495.5% |
| 2022 | 0.26x | ₫901.28 Billion | ₫233.99 Billion | ▲ +378.2% |
| 2021 | 0.05x | ₫452.44 Billion | ₫24.56 Billion | ▼ -49.5% |
| 2020 | 0.11x | ₫826.17 Billion | ₫88.81 Billion | ▲ +57.8% |
| 2019 | 0.07x | ₫838.24 Billion | ₫57.10 Billion | — |